GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE2370.55-25.85 (-1.08 %)
PREV CLOSE ( ) 2396.40
OPEN PRICE ( ) 2401.00
BID PRICE (QTY) 2370.55 (2)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2194
TODAY'S LOW / HIGH ( )2352.00 2438.00
52 WK LOW / HIGH ( )2309.05 2795
NSE2369.10-29.5 (-1.23 %)
PREV CLOSE( ) 2398.60
OPEN PRICE ( ) 2391.30
BID PRICE (QTY) 2369.10 (25)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 20541
TODAY'S LOW / HIGH( ) 2351.05 2415.00
52 WK LOW / HIGH ( )2201.2 2798.5
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 13-11 1924
Management Info
D S Parekh - Chairman A Vaidheesh - Managing Director
Registered Office

Address Dr Annie Besant Road,Worli,,
Mumbai,
Maharashtra-400030

Phone 022-24959595

Email askus@gsk.com

Website www.gsk-india.com

Registrars Details
Karvy Computershare Pvt Ltd
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE, MCX
NEWS
26Oct Glaxosmithkline Pharma reports 32% jum
Glaxosmithkline Pharmaceuticals has reported results for second quarter..
26Oct Glaxosmithkline Pharma soars on report
Glaxosmithkline Pharmaceuticals is currently trading at Rs. 2495.25, up..
25Oct Appointment of Chief Financial Office
Pursuant to Regulation 30 and Schedule III (A) (7) of the Listing and Di..
06Oct October 25, 2017
Pursuant to clause 33 of the Listing Obligations and Disclosure requirem..
25Sep GlaxoSmithKline Pharmaceuticals to sel
GlaxoSmithKline Pharmaceuticals has received an approval for sale of its..
Financials
Rs. in Millions
QTR Sep 17 ANNUAL 17
Net Profit1303.23367.8
Gross Profit 1991.3 5110.8
Operating Profit 20174917
Net Sales 8362.629945.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Dr. Reddys Lab (BSE)
 2372.00 (2.52%)
M.Cap (Rs. in Cr)39348.46
Merck (BSE)
 1211.35 (2.65%)
M.Cap (Rs. in Cr)2010.77
Torrent Pharma (BSE)
 1342.95 (2.13%)
M.Cap (Rs. in Cr)22725.77
Zandu Realty (BSE)
 1994.40 (1.39%)
M.Cap (Rs. in Cr)160.83
Pfizer (BSE)
 1995.70 (1.17%)
M.Cap (Rs. in Cr)9129.87
Shareholding Pattern
PROMOTERS 75%
NON-INSTITUTION 12.68%
FI/BANKS/INSURANCE 8.55%
MUTUAL FUNDS/UTI 2%
FII 0.01%
GOVERNMENT 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal, Tel no: 022-40790032, Mobile no- 9773104340, E-mail id- Complaince@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.